ArticleInvestigative ophthalmology & visual science2026
Real-Time High-Resolution OCT for Imaging Retinal and Choroidal Blood Flow.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the feasibility of visualizing intravascular moving particles within retinal and choroidal vessels using real-time high-resolution optical coherence tomography (High-Res OCT), a prototype device offering 3-µm axial resolution. Methods: In this cross-sectional study, 20 healthy eyes were imaged using both High-Res OCT and the standard SPECTRALIS HRA+OCT. A dedicated in-built research tool enabled ART-1 B-scan movie acquisition with real-time eye-tracking. Two masked graders qualitatively assessed visibility and direction of intravascular moving particles, and intergrader agreement was evaluated using Gwet's agreement coefficient 1 (AC1). Four additional patients with retinal vascular disorders (retinal artery occlusion, diabetic retinopathy, hypertensive retinopathy, and neovascular age-related macular degeneration) were imaged with High-Res OCT to explore illustrative clinical applications. Results: High-Res OCT demonstrated superior visualization of intravascular moving particles compared with standard OCT in both arteries (80% vs. 50%; P = 0.01) and veins (90% vs. 60%; P = 0.03). Intergrader agreement was high for High-Res OCT (AC1, 0.82-0.89) and moderate-to-substantial for standard OCT (AC1, 0.53-0.71). Flow direction assessment did not differ significantly between devices, although correct identification was numerically higher with High-Res OCT. In pathological eyes, real-time High-Res OCT enabled dynamic visualization of pulsatile and disturbed flow patterns and distinct intravascular motion across multiple vascular conditions. Conclusions: Real-time High-Res OCT enables direct, non-invasive visualization of intravascular moving particles within retinal and choroidal vessels and improves flow detectability compared with conventional OCT. This technique offers novel qualitative insights into ocular vascular dynamics and may guide future quantitative and translational applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.